177 related articles for article (PubMed ID: 35947343)
1. Use of Electrocardiogram Monitoring in Adult Patients Taking High-Risk QT Interval Prolonging Medicines in Clinical Practice: Systematic Review and Meta-analysis.
Putnikovic M; Jordan Z; Munn Z; Borg C; Ward M
Drug Saf; 2022 Oct; 45(10):1037-1048. PubMed ID: 35947343
[TBL] [Abstract][Full Text] [Related]
2. Use of ECG monitoring for adult patients taking high-risk QT interval-prolonging drugs in clinical practice: a systematic review protocol.
Putnikovic M; Ward M; Jordan Z
JBI Evid Synth; 2021 Nov; 19(11):3113-3120. PubMed ID: 34054036
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of QT interval prolongation in patients admitted to cardiac care units and frequency of subsequent administration of QT interval-prolonging drugs: a prospective, observational study in a large urban academic medical center in the US.
Tisdale JE; Wroblewski HA; Overholser BR; Kingery JR; Trujillo TN; Kovacs RJ
Drug Saf; 2012 Jun; 35(6):459-70. PubMed ID: 22612851
[TBL] [Abstract][Full Text] [Related]
4. Serial electrocardiogram recordings revealed a high prevalence of QT interval prolongation in patients with tuberculosis receiving fluoroquinolones.
Ju KS; Lee RG; Lin HC; Chen JH; Hsu BF; Wang JY; Van Dong N; Yu MC; Lee CH
J Formos Med Assoc; 2023 Dec; 122(12):1255-1264. PubMed ID: 37268474
[TBL] [Abstract][Full Text] [Related]
5. Methadone maintenance, QTc and torsade de pointes: who needs an electrocardiogram and what is the prevalence of QTc prolongation?
Mayet S; Gossop M; Lintzeris N; Markides V; Strang J
Drug Alcohol Rev; 2011 Jul; 30(4):388-96. PubMed ID: 21355918
[TBL] [Abstract][Full Text] [Related]
6. Are ECG monitoring recommendations before prescription of QT-prolonging drugs applied in daily practice? The example of haloperidol.
Warnier MJ; Rutten FH; Souverein PC; de Boer A; Hoes AW; De Bruin ML
Pharmacoepidemiol Drug Saf; 2015 Jul; 24(7):701-8. PubMed ID: 26013175
[TBL] [Abstract][Full Text] [Related]
7. Prevalence and determinants of QT interval prolongation in medical inpatients.
Pasquier M; Pantet O; Hugli O; Pruvot E; Buclin T; Waeber G; Aujesky D
Intern Med J; 2012 Aug; 42(8):933-40. PubMed ID: 21299787
[TBL] [Abstract][Full Text] [Related]
8. [Risk management of QT-prolonging drugs by community pharmacists using a mobile electrocardiograph].
Shinozaki K
Yakugaku Zasshi; 2010 Nov; 130(11):1597-601. PubMed ID: 21048421
[TBL] [Abstract][Full Text] [Related]
9. Underuse of ECG monitoring in oncology patients receiving QT-interval prolonging drugs.
Pezo RC; Yan AT; Earle C; Chan KK
Heart; 2019 Nov; 105(21):1649-1655. PubMed ID: 31129611
[TBL] [Abstract][Full Text] [Related]
10. Frequency of electrocardiogram testing among HIV-infected patients at risk for medication-induced QTc prolongation.
Patel N; Veve M; Kwon S; McNutt LA; Fish D; Miller CD
HIV Med; 2013 Sep; 14(8):463-71. PubMed ID: 23506263
[TBL] [Abstract][Full Text] [Related]
11. Accuracy of a single-lead mobile smartphone electrocardiogram for QT interval measurement in patients undergoing maintenance methadone therapy.
Titus-Lay EN; Jaynes HA; Tomaselli Muensterman E; Ott CA; Walroth TA; Williams G; Moe PR; Wilbrandt M; Tisdale JE
Pharmacotherapy; 2021 Jun; 41(6):494-500. PubMed ID: 33772822
[TBL] [Abstract][Full Text] [Related]
12. A review of ECG and QT interval measurement use in a public psychiatric inpatient setting.
Berling I; Gupta R; Bjorksten C; Prior F; Whyte IM; Berry S
Australas Psychiatry; 2018 Feb; 26(1):50-55. PubMed ID: 28836822
[TBL] [Abstract][Full Text] [Related]
13. Incidence and outcomes of long QTc in acute medical admissions.
Mahmud R; Gray A; Nabeebaccus A; Whyte MB
Int J Clin Pract; 2018 Nov; 72(11):e13250. PubMed ID: 30222237
[TBL] [Abstract][Full Text] [Related]
14. [Cardiological monitoring of antipsychotic-treated patients: evaluation and evolution of a hospital protocol].
Frimas V; Roberge C; Perroux D; Dauvillier JM
Encephale; 2008 Oct; 34(5):467-76. PubMed ID: 19068335
[TBL] [Abstract][Full Text] [Related]
15. QTc prolongation in adolescents with acute alcohol intoxication.
de Veld L; van der Lely N; Hermans BJM; van Hoof JJ; Wong L; Vink AS
Eur J Pediatr; 2022 Jul; 181(7):2757-2770. PubMed ID: 35482092
[TBL] [Abstract][Full Text] [Related]
16. High prevalence of corrected QT interval prolongation in acutely ill patients is associated with mortality: results of the QT in Practice (QTIP) Study.
Pickham D; Helfenbein E; Shinn JA; Chan G; Funk M; Weinacker A; Liu JN; Drew BJ
Crit Care Med; 2012 Feb; 40(2):394-9. PubMed ID: 22001585
[TBL] [Abstract][Full Text] [Related]
17. Number of ECG Replicates and QT Correction Formula Influences the Estimated QT Prolonging Effect of a Drug.
van der Wall HEC; Gal P; Kemme MJB; van Westen GJP; Burggraaf J
J Cardiovasc Pharmacol; 2019 Apr; 73(4):257-264. PubMed ID: 30762613
[TBL] [Abstract][Full Text] [Related]
18. The prevalence of QT prolongation in a population of patients with substance use disorders.
Scott AJ; Dunlop AJ; Brown A; Sadler C; Isbister GK
Drug Alcohol Rev; 2017 Mar; 36(2):239-244. PubMed ID: 27241860
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of QT-Prolonging Drug-Drug Interactions in Psychiatry: A Systematic Review and Meta Analysis.
Ramasubbu SK; Mishra A; Mandal S
J Pharm Pract; 2024 Feb; 37(1):162-168. PubMed ID: 35968552
[No Abstract] [Full Text] [Related]
20. Prevalence and Risk Factors of Drug-Associated Corrected QT Prolongation in Elderly Hospitalized Patients: Results of a Retrospective Analysis of Data Obtained Over 6 Months.
Maison O; de la Gastine B; Dayot L; Goutelle S
Drugs Aging; 2017 Jul; 34(7):545-553. PubMed ID: 28577045
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
